Bionano Genomics (BNGO) Other Operating Expenses (2017 - 2024)
Bionano Genomics (BNGO) reported Other Operating Expenses of $138000.0 for Q4 2024, down 81.38% on a YoY basis from $741000.0 in Q1 2024, and down 99.35% sequentially from $21.3 million in Q3 2024.
Bionano Genomics (BNGO) Other Operating Expenses (2017 - 2024) Analysis & Trends
Bionano Genomics (BNGO) has 5 years of Other Operating Expenses data on file, last reported at $138000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Operating Expenses fell 81.38% year-over-year to $138000.0; the trailing twelve-month figure through Sep 2025 stood at $138000.0 (down 99.51% YoY), and the FY2024 full-year result was $27.7 million, down 64.49% from the prior year.
- Other Operating Expenses retreated to $138000.0 in Q4 2024, from $21.3 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $77.3 million in Q3 2023 to a low of $138000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Bionano Genomics | 4.34 Mn | -9.35 Mn | 3.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | 21.27 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 741,000.00 |
| Sep 30, 2023 | 77.28 Mn |
| Dec 31, 2019 | -403.00 |
| Dec 31, 2018 | 1.00 |
| Dec 31, 2017 | 604,511.00 |